Monash IVF Group (MIS) Stock Overview

Engages in the provision of assisted reproductive and specialist women imaging services in Australia and Malaysia. More details

MIS fundamental analysis
Snowflake Score
Valuation	4/6
Future Growth	1/6
Past Performance	2/6
Financial Health	3/6
Dividends	3/6

Rewards

Trading at 71.5% below our estimate of its fair value

Earnings are forecast to grow 17.08% per year

Became profitable this year

Risk Analysis

Dividend of 7.59% is not well covered by free cash flows

MIS Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

View all narratives

Monash IVF Group Limited Competitors

Price History & Performance

Summary of share price highs, lows and changes for Monash IVF Group
Historical stock prices
Current Share Price	AU$0.39
52 Week High	AU$0.48
52 Week Low	AU$0.32
Beta	0.39
1 Month Change	-9.30%
3 Month Change	2.63%
1 Year Change	15.38%
3 Year Change	-43.88%
5 Year Change	-24.27%
Change since IPO	-66.06%

Recent updates

Shareholder Returns

	MIS	DE Healthcare	DE Market
7D	-3.0%	2.6%	-0.2%
1Y	15.4%	-14.9%	1.4%

Return vs Industry: MIS exceeded the German Healthcare industry which returned -14.9% over the past year.

Return vs Market: MIS exceeded the German Market which returned 1.4% over the past year.

Price Volatility

Is MIS's price volatile compared to industry and market?
MIS volatility
MIS Average Weekly Movement	8.2%
Healthcare Industry Average Movement	6.7%
Market Average Movement	6.0%
10% most volatile stocks in DE Market	13.1%
10% least volatile stocks in DE Market	2.8%

Stable Share Price: MIS has not had significant price volatility in the past 3 months compared to the German market.

Volatility Over Time: MIS's weekly volatility (8%) has been stable over the past year.

About the Company

Founded	Employees	CEO	Website
2014	892	Victoria Atkinson	www.monashivfgroup.com.au

Monash IVF Group Limited engages in the provision of assisted reproductive and specialist women imaging services in Australia and Malaysia. It offers diagnostic obstetric, gynecological ultrasound, and fertility treatment services. It also provides tertiary level prenatal diagnostic, and IVF treatment services.

Monash IVF Group Limited Fundamentals Summary

How do Monash IVF Group's earnings and revenue compare to its market cap?
MIS fundamental statistics
Market cap	€162.54m
Earnings (TTM)	€9.23m
Revenue (TTM)	€164.06m

17.6x

P/E Ratio

1.0x

P/S Ratio

Is MIS overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
MIS income statement (TTM)
Revenue	AU$269.39m
Cost of Revenue	AU$185.18m
Gross Profit	AU$84.22m
Other Expenses	AU$69.06m
Earnings	AU$15.16m

Last Reported Earnings

Dec 31, 2025

Next Earnings Date

Aug 24, 2026

Earnings per share (EPS)	0.039
Gross Margin	31.26%
Net Profit Margin	5.63%
Debt/Equity Ratio	39.8%

How did MIS perform over the long term?

See historical performance and comparison

Dividends

7.6%

Current Dividend Yield

31%

Payout Ratio

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/06/15 18:52
End of Day Share Price	2026/06/12 00:00
Earnings	2025/12/31
Annual Earnings	2025/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Monash IVF Group Limited is covered by 14 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Martyn Jacobs	Bell Potter
Bradley Watson	Bell Potter
Tara Speranza	Bell Potter

Monash IVF Group (MIS) Stock Overview

Rewards

Risk Analysis

Monash IVF Group Limited Competitors

LIMES Schlosskliniken

MEDICLIN

M1 Kliniken

RHÖN-KLINIKUM

Price History & Performance

Recent News & Updates

WHSP Holdings Limited (ASX:SOL) and Genesis Capital cancelled the acquisition of 80.4% stake in Monash IVF Group Limited (ASX:MVF).

Monash IVF Group Limited Announces Ordinary Fully Franked Interim Dividend for the Period Ended December 31, 2025, Payable on 10 April 2026

Monash IVF Group Limited Announces Resignation of Malik Jainudeen as Company Secretary, Effective End of April 2026

Monash IVF Group Limited to Report Fiscal Year 2026 Results on Aug 24, 2026

Monash IVF Group Limited to Report First Half, 2026 Results on Feb 26, 2026

WHSP Holdings Limited (ASX:SOL) and Genesis Capital cancelled the acquisition of remaining 80.4% stake in Monash IVF Group Limited (ASX:MVF) for approximately AUD 250 million.

Recent updates

WHSP Holdings Limited (ASX:SOL) and Genesis Capital cancelled the acquisition of 80.4% stake in Monash IVF Group Limited (ASX:MVF).

Monash IVF Group Limited Announces Ordinary Fully Franked Interim Dividend for the Period Ended December 31, 2025, Payable on 10 April 2026

Monash IVF Group Limited Announces Resignation of Malik Jainudeen as Company Secretary, Effective End of April 2026

Monash IVF Group Limited to Report Fiscal Year 2026 Results on Aug 24, 2026

Monash IVF Group Limited to Report First Half, 2026 Results on Feb 26, 2026

WHSP Holdings Limited (ASX:SOL) and Genesis Capital cancelled the acquisition of remaining 80.4% stake in Monash IVF Group Limited (ASX:MVF) for approximately AUD 250 million.

Monash IVF Group Limited, Annual General Meeting, Nov 20, 2025

Monash IVF Group Limited Announces CEO Changes

Monash IVF Group Limited Declares Fully Franked Interim Dividend for the First Half ended 31 December 2024, Payable on 11 April 2025

Monash IVF Group Limited to Report Fiscal Year 2025 Results on Aug 22, 2025

Insufficient new directors

New minor risk - Share price stability

Monash IVF Group Limited Announces Board Changes

Independent Non-Executive Director recently bought €57k worth of stock

Monash IVF Group Limited Announces Ordinary Fully Franked Dividend for the Six Months Ended June 30, 2024, Payable on October 11, 2024

Full year 2024 earnings released: AU$0.017 loss per share (vs AU$0.056 profit in FY 2023)

Monash IVF Group Limited (ASX:MVF)completed the acquisition of 80% stake in Fertility North Holdings Pty Ltd.

Upcoming dividend of AU$0.025 per share

Monash IVF Group Limited Appoints Cathy Aston as an Independent Non-Executive Director and A Member of the Audit and Risk Management Committee Effective from 26 February 2024

First half 2024 earnings released: EPS: AU$0.033 (vs AU$0.027 in 1H 2023)

First half dividend of AU$0.025 announced

Monash IVF Group Limited to Report First Half, 2024 Results on Feb 23, 2024

Upcoming dividend of AU$0.022 per share at 3.5% yield

Monash IVF Group Limited Announces Fully Franked Final Dividend for Fiscal Year Ended June 30, 2023, Payable on 11 October 2023

Full year 2023 earnings released: EPS: AU$0.056 (vs AU$0.047 in FY 2022)

Monash IVF Group Limited Provides Update on Class Action Lawsuit

Monash IVF Group Limited (ASX:MVF) completed the acquisition of PIVET Medical Centre.

Upcoming dividend of AU$0.022 per share at 4.2% yield

First half 2023 earnings released: EPS: AU$0.027 (vs AU$0.031 in 1H 2022)

Monash IVF Group Limited to Report First Half, 2023 Results on Feb 21, 2023

Insufficient new directors

Upcoming dividend of AU$0.022 per share

Full year 2022 earnings released: EPS: AU$0.047 (vs AU$0.065 in FY 2021)

Insufficient new directors

Insufficient new directors

Upcoming dividend of AU$0.021 per share

Full year 2021 earnings released: EPS AU$0.065 (vs AU$0.046 in FY 2020)

Independent Non-Executive Director recently bought €124k worth of stock

Revenue beats expectations

First half 2021 earnings released: EPS AU$0.037 (vs AU$0.035 in 1H 2020)

New 90-day high: €0.51

New 90-day high: €0.48

New 90-day high: €0.44

Shareholder Returns

Price Volatility

About the Company

Monash IVF Group Limited Fundamentals Summary

Earnings & Revenue

Dividends

Company Analysis and Financial Data Status

Data Sources

Analysis Model and Snowflake

Industry and Sector Metrics

Analyst Sources